Introduction
============

Genome-wide association studies (GWAS) are routinely used in the search for genes associated with complex traits. Often, a test of association with a phenotype of interest is performed for each single-nucleotide polymorphism (SNP) independently and pair-wise tests of interaction are used to find gene × gene interaction. In GWAS, performing all pair-wise interaction tests can be an intractable task, especially if logistic regression with covariate adjustments is used. It is imperative to develop strategies to search out gene × gene interaction in the context of GWAS. In this paper, we apply two screening approaches to reduce the number of tests performed.

The strongest known genetic association with rheumatoid arthritis (RA) is the *HLA-DRB1*locus, which is part of the major histocompatibility complex on chromosome 6. After performing a GWAS analysis that adjusted for SNPs capturing the strong association signal from the *HLA-DRB1*locus, we used a permutation approach to evaluate sets of candidate SNPs to determine if these sets yielded an excess of significant main effects and SNP × SNP interaction effects over what would be expected by chance.

We defined candidate sets of SNPs using two methods. The first method, suggested by Kooperberg and Leblanc \[[@B1]\], tests for pair-wise interaction between SNPs with significant main effects, defined here as having main effect *p*-values less than 1 × 10^-4^. In the second method, we used biological processes to define gene collections and searched for significant main effects and pair-wise interaction effects among SNPs near these genes. We sought to evaluate this gene-based approach in collections containing at least one of four genes having known associations with RA: *PTPN22*\[[@B2],[@B3]\], *STAT4*\[[@B4]\], *TRAF1*, and *C5*\[[@B5]\]. After a set of SNPs from either of these two methods was found to have empirical enrichment of significant interaction effects in models unadjusted for the *HLA-DRB1*locus, we then evaluated pairwise interactions adjusting for SNPs that capture the signal from the *HLA-DRB1*locus.

Methods
=======

Study sample and genotyping
---------------------------

The study sample for this research consists of 2,062 individuals in the North American Rheumatoid Arthritis Consortium (NARAC), 868 who had RA and 1,194 who did not. Genotyping of the sample was performed on Infinium HumanHap550 arrays, version 1.0 (Illumina) and is described elsewhere \[[@B5]\]. In total, genotypes for 545,080 SNPs were made available to our study. The analysis of this data was performed as part of the Genetic Analysis Workshop 16.

The study sample and genotype data were cleaned using utilities in the PLINK software package, version 1.02 \[[@B6]\]. Individuals were removed from the sample if their reported sex did not match their estimated sex given their genotypes on the X chromosome. Additional individual-level cleaning consisted of checking the number of missing genotypes per person, a test of missingness by case-control status, and a haplotype test for non-random missing genotypes with respect to case-control status. SNPs were removed from the analysis if the call rate was less than 95%, the minor allele frequency was less than 1%, the Hardy-Weinberg equilibrium *p*-value was less than 10^-4^, or a test for differential missingness between cases and controls resulted in a *p*-value \< 10^-4^. After filtering, the sample consisted of 2,055 individuals and 495,766 SNPs.

Statistical analysis
--------------------

Statistical analyses were performed using PLINK, version 1.02 \[[@B6]\] and the statistical package R, version 2.6.1. The association between each SNP and RA was assessed with logistic regression adjusting for sex and specific genetic loci as described below. In the case of the gene-centric analysis, we defined sets of SNPs as described below and used PLINK to perform tests of main effects and interaction with these SNPs. The pair-wise tests of interactions for the permutations described below were performed using the\--*fast-epistasis*command in PLINK. Sets of SNPs that were enriched with significant pair-wise interactions were further evaluated using logistic regression models in R, which included SNPs explaining the association signals in the HLA-DRB1 locus.

Adjusting for *HLA-DRB1*
------------------------

It is well known that specific alleles at the *HLA-DRB1*locus in 6p21 are strongly associated with RA. The literature suggests two classes of alleles: the highest risk alleles are *DRB1\*0401*, *0404*, *0405*, *0408*, and *0409*, and other risk alleles are *DRB1\*0101*, *0102*, *0104*, *0105*, *1001*, *1402*, and *1406*\[[@B7]\]. In our genome-wide search for significant interacting and main effects we performed analyses adjusting for the number of high risk and other risk alleles for each individual.

After adjusting for the *HLA-DRB1*locus, highly significant SNPs remained in the 6p21 region surrounding the *HLA-DRB1*locus. We added SNPs to our model, one at a time, until the most significant SNP on chromosome 6 was no longer in the 6p21 region.

Enrichment of interaction effects among SNPs with significant main effects
--------------------------------------------------------------------------

Kooperberg and Leblanc \[[@B1]\] suggest that there is more power to detect gene × gene interaction effects if tests for interaction are limited to those SNPs with significant main effects, thus limiting the number of tests performed. We defined statistical significance of main effects using a *p*-value cut-off of 1 × 10^-4^, a less conservative choice than the Bonferroni significance cut-off of 0.05/545,080 = 9.17 × 10^-7^. We then performed pair-wise interaction tests among all SNPs that passed quality control filters and had statistically significant main effects. Significance of interaction *p*-values was determined with a Bonferroni correction on the number of tests performed.

In order to determine whether this set of SNPs was enriched with more significant interaction effects than would be expected by chance, we employed a permutation approach to construct a null distribution for the proportion of interaction *p*-values less than the alpha level determined by the Bonferroni correction. We permuted the phenotype and covariates of our sample 1,000 times. For each permutation, we performed a genome-wide scan of single-SNP association, chose those SNPs with *p*-values \< 10^-4^, and performed pair-wise interaction tests with this set of SNPs. The null distribution from which we determine significant enrichment of interaction *p*-values was built from the number of tests with *p*-values less than the Bonferroni correction from each permutation.

Enrichment of main and interaction effects among SNPs in gene collections
-------------------------------------------------------------------------

Four genes that are known to be associated with RA are *PTPN22*, *STAT4*, *TRAF1*, and *C5*. In the case of *TRAF1*and *C5*, a SNP was found to be associated with RA and is in linkage disequilibrium with both the *TRAF1*and *C5*genes; the causal variant(s) among these genes have yet to be determined. We identified pathways and gene collections containing these four genes from two sources: the Kyoto Encyclopedia of Genes and Genomes (KEGG) \[[@B8]-[@B10]\] and the Gene Ontology (GO) project \[[@B11]\]. Two genes were found in KEGG pathways. The *TRAF1*gene is in the \"small cell lung cancer\" pathway and *STAT4*is in the \"JAK-STAT signaling\" pathway. We used GO data sets to extract sets to which our genes are annotated in the Biological Process ontology. To avoid overly narrow or broad sets, we focused on GO sets that contained at least 30, but no more than 220, genes. We considered the following GO sets: \"protein amino acid dephosphorylation\" for *PTPN22*; \"JAK-STAT cascade\" for *STAT4*; \"protein complex assembly\" for *TRAF1*; \"activation of MAPK activity\", \"chemotaxis\", and \"inflammatory response\" for the *C5*gene.

In the analysis of each gene collection, we used a permutation approach to determine whether the gene collection was significantly enriched with *p*-values \< 10^-6^, 10^-7^, and 10^-8^. The phenotypes of our sample were permuted and pair-wise tests of interaction were performed with the SNPs in the gene collection. The observed number of SNPs with main effect *p*-values \< 10^-6^, 10^-7^, and 10^-8^was noted for each permutation, as was the number of pair-wise interaction tests with *p*-values below the same thresholds. A null distribution of both main effect and interaction *p*-values below each threshold was built from 1,000 permutations. Significant enrichment of main effect and interaction *p*-values was determined by comparing the proportion of *p*-values less than each threshold in the set of SNPs in the gene collection with the empirical null distribution at that threshold.

Results
=======

Adjusting for *HLA-DRB1*
------------------------

Our analysis of main effect associations of SNPs was adjusted for the *HLA-DRB1*locus on 6p24, using two covariates indicating the number of risk alleles per person as well as five SNPs in the immediate vicinity of the gene. These SNPs, with their gene and *p*-value from the adjusted model are: rs9391858 (*C6orf10*, 1.7 × 10^-33^), rs660895 (*HLA-DRB1*, 7.7 × 10^-19^), rs2395175 (*HLA-DRA*, 5.1 × 10^-16^), rs2524123 (*HLA-C*, 9.3 × 10^-8^), and rs3130237 (*COL11A2*, 1.62 × 10^-8^). From the same model, the variable indicating the number of high-risk *HLA-DRB1*alleles and the variable indicating the number of other risk alleles had *p*-values of 0.017 and 0.79, respectively. After applying this adjusted model on all other chromosome 6 SNPs, the most significant SNP was rs11964472 (*p*-value 1.8 × 10^-6^), located near the *PAQR8*and *MCM3*genes on 6p12.

Pair-wise interaction tests among these four SNPs and the number of *HLA-DRB1*risk alleles indicate that no significant interaction exists among the four SNPs in the adjusted model or the number of *HLA-DRB1*risk alleles.

Enrichment of interaction effects among SNPs with significant main effects
--------------------------------------------------------------------------

We sought to find significant SNP × SNP interactions among the SNPs with significant main effects after adjustment for the number of high-risk *HLA-DRB1*alleles, the number of other risk alleles, and the five SNPs near the *HLA-DRB1*locus. Of the genome-wide SNPs passing quality control filters, 178 had main effect *p*-values \< 10^-4^.

This set of SNPs was significantly enriched with interaction *p*-values \< 10^-4^based on permutation tests. We performed 15,383 unadjusted pair-wise interaction tests with these SNPs. Using a Bonferroni correction, the *p*-value cut-off for significance would be 0.05/15,383 = 3.25 × 10^-6^. Of the 15,383 unadjusted pair-wise tests, two tests had *p*-values \< 3.17 × 10^-6^with a permutation *p*-value of 0.003, indicating significant enrichment of interaction effects in this set of SNPs. In the adjusted models, which adjust for the strong signal in *HLA-DRB1*, the most significant interaction effect occurred between rs1333914 in *DBC1*on chromosome 9 and *C6orf10*on chromosome 6, with an interaction *p*-value of 5.7 × 10^-5^. The top ten results of the adjusted pair-wise interaction analyses are presented in Table [1](#T1){ref-type="table"}.

###### 

Top ten pair-wise interaction results among SNPs with main-effects *p*-values \< 1 × 10^-4^from logistic regression models

  SNP 1        Chr   Position (1,000 bp)   Closest gene   SNP 2          Chr   Position (1,000 bp)   Closest gene   Interaction *p*-value
  ------------ ----- --------------------- -------------- -------------- ----- --------------------- -------------- -----------------------
  rs1333914    9     121623                *DBC1*         rs9391858^a^   6     32449                 *C6orf10*      5.7 × 10^-5^
  rs9368950    6     36736                 *CDKN1A*       rs9408926      9     122955                *CEP110*       5.7 × 10^-5^
  rs3873444    6     32791                 *HLA-DQA2*     rs17172185     7     43253                 *HECW1*        1.1 × 10^-4^
  rs9368950    6     36736                 *CDKN1A*       rs9408928      9     122992                *RAB14*        1.9 × 10^-4^
  rs7679231    4     137102                *PCDH18*       rs8017455      14    80645                 *TSHR*         2.4 × 10^-4^
  rs532098     6     32686                 *HLA-DRB1*     rs660895^a^    6     32685                 *HLA-DRB1*     2.6 × 10^-4^
  rs4674520    2     201422                *CLK1*         rs2524123^a^   6     31373                 *HLA-C*        3.3 × 10^-4^
  rs10948693   6     52262                 *MCM3*         rs7330752      13    29755                 *KATNAL1*      3.8 × 10^-4^
  rs4674520    2     201427                *CLK1*         rs10948693     6     52262                 *MCM3*         4.0 × 10^-4^

^a^SNPs from the adjusted model

Enrichment of main and interaction effects among SNPs in gene collections
-------------------------------------------------------------------------

Using sets of SNPs in biologically derived gene collections, we used permutations to establish the significance of the proportion of main effects and interaction effects below certain *p*-value thresholds. The results of this analysis are presented in Table [2](#T2){ref-type="table"}. Of interest are two gene collections that contain the *TRAF1*gene. SNPs near *TRAF1*account for the most significant signals in the GWAS (rs2900180, *p*= 2.1 × 10^-9^) after adjusting for the *HLA-DRB1*locus. The \"small cell lung cancer\" KEGG pathway, which contains the *TRAF1*gene, is significantly enriched with significant main effect *p*-values, but not with significant interaction effects. The enrichment of main effects *p*-values is driven by the significant SNPs in the *TRAF1*gene. On the other hand, the \"protein complex assembly\" set of SNPs from GO is significantly enriched with both significant main effects and interaction effects. Two genes in this set, *TRAF1*and *TAP2*, have significant main effects after adjusting for the *HLA-DRB1*locus, which is very close to the *HLA-DRB1*locus. Among the SNPs within 60 kb of the *TAP2*gene, unadjusted interaction *p*-values were as low as 1 × 10^-20^. Such high significance is most likely due to the unadjusted nature of the tests for interaction using the\--fast-epistasis command in PLINK: SNPs within *TAP2*capture the strong signal present in the region.

###### 

Number of tests with *p*-values \< 10^-6^, 10^-7^, 10^-8^

                                                                                          No. *p*-Values below threshold^a^(permutation *p*-value)                 
  -------------------------------------- ------ -------- ----- -------------- ----------- ---------------------------------------------------------- ------------- -------------
  Small cell lung cancer                 KEGG   TRAF1    87    Main effects   3,429       6 (\<0.001)                                                6 (\<0.001)   3 (\<0.001)
                                                               Interaction    5,800,955   8 (0.081)                                                  0 (1)         0 (1)
  JAK-STAT signaling pathway             KEGG   STAT4    153   Main effects   3,253       0 (1)                                                      0 (1)         0 (1)
                                                               Interaction    5,169,188   7 (0.137)                                                  3 (0.029)     0 (1)
  Protein complex assembly               GO     TRAF1    214   Main effects   3,883       6 (\<0.001)                                                6 (\<0.001)   3 (\<0.001)
                                                               Interaction    7,277,905   292 (0.642)                                                193 (0.152)   151 (0.012)
  Protein amino acid dephosphorylation   GO     PTPN22   73    Main effects   2,277       0 (1)                                                      0 (1)         0 (1)
                                                               Interaction    2,496,978   1 (0.735)                                                  0 (1)         0 (1)
  JAK-STAT cascade                       GO     STAT4    41    Main effects   761         0 (1)                                                      0 (1)         0 (1)
                                                               Interaction    289,031     0 (1)                                                      0 (1)         0 (1)
  Activation of MAPK activity            GO     C5       47    Main effects   785         3 (\<0.001)                                                3 (\<0.001)   1 (\<0.001)
                                                               Interaction    307,355     0 (1)                                                      0 (1)         0 (1)
  Chemotaxis                             GO     C5       112   Main effects   1,470       3 (\<0.001)                                                3 (\<0.001)   1 (\<0.001)
                                                               Interaction    1,065,328   1 (0.467)                                                  0 (1)         0 (1)
  Inflammatory response                  GO     C5       180   Main effects   2,535       3 (\<0.001)                                                3 (\<0.001)   1 (\<0.001)
                                                               Interaction    3,163,945   8 (0.025)                                                  0 (1)         0 (1)

^a^Empirical significance was determined by comparing the number of *p*-values below each threshold to a null distribution of the number obtained by permuting the phenotypes and performing main effects and interaction tests with the permuted data set.

^b^Interaction tests are unadjusted.

We subsequently studied the pair-wise interaction between SNPs in the \"protein complex assembly\" gene collection using logistic regression models that adjusted for the *HLA-DRB1*locus. Because there are a large number of genes and SNPs in this collection (214 and 3,883 respectively), we filtered the number of SNPs by main effects *p*-values = 0.20 and *r*^2^\> 0.5, for a total of 572 SNPs. The top ten results observed among these tests are presented in Table [3](#T3){ref-type="table"}.

###### 

The top ten pair-wise interaction results among SNPs near genes in the \"protein complex assembly\" gene collection from a logistic regression model

  SNP 1        Chr   Closet gene   SNP 2          Chr   Closet gene   Interaction *p*-value
  ------------ ----- ------------- -------------- ----- ------------- -----------------------
  rs12969200   18    *DSG1*        rs12458537     18    *MALT1*       1.05 × 10^-7^
  rs215590     16    *MYH11*       rs9391858^b^   6     *C6orf10*     1.86 × 10^-6^
  rs13035837   2     *DGKD*        rs2672221      11    *NUP98*       3.27 × 10^-6^
  rs335524     1     *CENPF*       rs215590       16    *MYH11*       1.31 × 10^-5^
  rs10834677   11    *ART5*        rs17286488     16    *MYH11*       2.21 × 10^-5^
  rs1553920    1     *PIK3C2B*     rs6888329      5     *ADRB2*       5.38 × 10^-5^
  rs9311951    3     *MAGI1*       rs2191498      7     *CAV2*        5.64 × 10^-5^
  rs774265     7     *SKAP2*       rs1412243      9     *APBA1*       8.64 × 10^-5^
  rs10739575   9     *PSMD5*       rs1805061      14    *SLC7A7*      9.88 × 10^-5^

^a^SNPs were filtered by main effects *p*-values = 0.20 and binned by *r*^2^\> 0.5, for a total of 572 SNPs

^b^SNPs from the adjustment model

Discussion
==========

We found that the set of SNPs with significant main effects was enriched with significant interaction effects, using an interaction *p*-value cut-off of 3.17 × 10^-6^. In using biological information from the KEGG and GO databases, significant enrichment of low-interaction *p*-values was observed when genes such as *TRAF1*and *TAP2*were included in the gene sets. These genes were close to the most significant regions in the GWAS. None of the other gene sets were found to be enriched with significant main effects or pair-wise interactions.

Despite these promising findings, both methods of selecting SNPs for tests of interactions have disadvantages. When selecting SNPs with significant main effects, those interactions among SNPs without main effects will be missed. The justification for the approach is the gain in power by testing fewer SNPs. The power to detect interaction in the absence of main effects is very low when tests of interaction are performed in the entire genome due to the number of tests being performed. In the selection of SNPs using \"expert knowledge\" from biological databases, the quality of the gene sets is only as good as the quality of the database. The curation of these databases is a developing science and there are many reasons to believe that the quality of these resources and the data they provide will continue to improve.
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